Gemcitabine-based therapy in pancreas cancer: gemcitabine-docetaxel and other novel combinations.
about
Biweekly triple combination chemotherapy with gemcitabine, oxaliplatin, levofolinic acid and 5-fluorouracil (GOLF) is a safe and active treatment for patients with inoperable pancreatic cancer.Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 functionAdvanced pancreatic cancer: is there a role for combination therapy?Antitumor activity of sugar-modified cytosine nucleosides.A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid.UA62784, a novel inhibitor of centromere protein E kinesin-like proteinSignificance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer.K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.Gemcitabine (GEM), 5-fluorouracil (5-FU) and folinic acid (FA) in patients with different gastroenteric malignancies.Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.Review on gold nanoparticles and their applications
P2860
Q33378968-96CE72AF-A518-44D4-BC02-44687A981094Q33684453-242BFAE2-E644-4C75-B2F4-B0E0E220E7C5Q33930068-5A1017BC-3047-4296-B133-C8382BA8252AQ35576200-013CC0E1-F9C2-47BD-9155-B10BF2DF48DFQ35668415-EB72D2F2-6EA8-45B6-96DF-CCA83FD96449Q36670901-8260714F-C1F6-48D0-AB3F-03CADE13AEB5Q37081499-3A01BCF7-CDC5-40EC-980C-7A68BC4224FDQ39466674-DD10A6D6-3D7D-45B0-944F-8B9CCF79C86AQ40134965-66424910-8FCF-44CA-923D-249A0681531EQ40391830-02761AFF-5326-409E-BC63-17A164F78793Q40411418-98A9ED05-E5D4-410F-82CB-F0C47CDC203BQ44951218-8D2DCAFD-1FAB-4FAD-B2E6-A385B204C4BBQ46845221-D7CB889D-94FA-4F35-8A66-23A348BBC00AQ46941754-8A558250-D38A-4A52-B7F2-DCF632CBE523Q57348809-51457426-8AC2-4CE3-AE5F-C7C48B5FF618
P2860
Gemcitabine-based therapy in pancreas cancer: gemcitabine-docetaxel and other novel combinations.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Gemcitabine-based therapy in p ...... and other novel combinations.
@ast
Gemcitabine-based therapy in p ...... and other novel combinations.
@en
Gemcitabine-based therapy in p ...... and other novel combinations.
@nl
type
label
Gemcitabine-based therapy in p ...... and other novel combinations.
@ast
Gemcitabine-based therapy in p ...... and other novel combinations.
@en
Gemcitabine-based therapy in p ...... and other novel combinations.
@nl
prefLabel
Gemcitabine-based therapy in p ...... and other novel combinations.
@ast
Gemcitabine-based therapy in p ...... and other novel combinations.
@en
Gemcitabine-based therapy in p ...... and other novel combinations.
@nl
P2860
P356
P1433
P1476
Gemcitabine-based therapy in p ...... and other novel combinations.
@en
P2093
Andrew D Jacobs
P2860
P304
P356
10.1002/CNCR.10756
P407
P433
P577
2002-08-01T00:00:00Z